Literature DB >> 2787848

Cerebral metabolism of L-[2-18F]fluorotyrosine, a new PET tracer of protein synthesis.

H H Coenen1, P Kling, G Stöcklin.   

Abstract

L-[2-18F]fluorotyrosine (2-18FTyr) was evaluated as a tracer of cerebral protein synthesis for positron emission tomography (PET). Its metabolism in murine cerebrum was studied. The uptake in brain reaches a value of approximately 2% of the injected dose per gram tissue after 60 min. The incorporation of the tracer into tissue proteins was proven by discontinuous SDS gel electrophoresis. The protein bound fraction of tissue activity increased to 84% and 89% after 60 and 120 min p.i., respectively. High performance liquid chromatography analysis showed a concomitant decrease of free 2-18FTyr in tissue with time. The sum of free 2-18FTyr, tRNA-and protein-bound 2-18FTyr in cerebral tissue gave an almost quantitative activity balance of 96 +/- 4% at all times examined. A significant formation of fluorodopa or fluorodopamine must therefore be excluded. This shows that L-[2-18F]fluorotyrosine is a promising tracer for quantitation of protein synthesis rates with PET based on a three-compartment model.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2787848

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  16 in total

Review 1.  Approaches to the design of biochemical probes for positron emission tomography.

Authors:  J R Barrio
Journal:  Neurochem Res       Date:  1991-09       Impact factor: 3.996

Review 2.  Tracers for metabolic imaging of brain and heart. Radiochemistry and radiopharmacology.

Authors:  G Stöcklin
Journal:  Eur J Nucl Med       Date:  1992

3.  O-[18F]fluoromethyl-L-tyrosine is a potential tracer for monitoring tumour response to chemotherapy using PET: an initial comparative in vivo study with deoxyglucose and thymidine.

Authors:  Gengo Yamaura; Takashi Yoshioka; Hiroshi Fukuda; Keichiro Yamaguchi; Manami Suzuki; Shozo Furumoto; Ren Iwata; Chikashi Ishioka
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-06-09       Impact factor: 9.236

4.  Preclinical evaluation of an 18F-trifluoroborate methionine derivative for glioma imaging.

Authors:  Xiangyu Yang; Zhibo Liu; Huimin Zhang; Zhu Li; Jeeva P Munasinghe; Gang Niu; Gaojun Teng; Xiaoyuan Chen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-12-29       Impact factor: 9.236

Review 5.  Fluorinated tracers for imaging cancer with positron emission tomography.

Authors:  Olivier Couturier; André Luxen; Jean-François Chatal; Jean-Philippe Vuillez; Pierre Rigo; Roland Hustinx
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-07-06       Impact factor: 9.236

6.  Serotonin synthesis, release and reuptake in terminals: a mathematical model.

Authors:  Janet Best; H Frederik Nijhout; Michael Reed
Journal:  Theor Biol Med Model       Date:  2010-08-19       Impact factor: 2.432

7.  Regional rates of cerebral protein synthesis measured with L-[1-11C]leucine and PET in conscious, young adult men: normal values, variability, and reproducibility.

Authors:  Shrinivas Bishu; Kathleen C Schmidt; Thomas Burlin; Michael Channing; Shielah Conant; Tianjiang Huang; Zhong-hua Liu; Mei Qin; Aaron Unterman; Zengyan Xia; Alan Zametkin; Peter Herscovitch; Carolyn B Smith
Journal:  J Cereb Blood Flow Metab       Date:  2008-05-21       Impact factor: 6.200

8.  3-O-methyl-6-[18F]fluoro-L-DOPA and its evaluation in brain tumour imaging.

Authors:  B Beuthien-Baumann; J Bredow; W Burchert; F Füchtner; R Bergmann; H-D Alheit; G Reiss; R Hliscs; R Steinmeier; W-G Franke; B Johannsen; J Kotzerke
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-05-24       Impact factor: 9.236

9.  Gliomatosis cerebri evaluated by 18Falpha-methyl tyrosine positron-emission tomography.

Authors:  N Sato; T Inoue; K Tomiyoshi; J Aoki; N Oriuchi; A Takahashi; T Otani; H Kurihara; T Sasaki; K Endo
Journal:  Neuroradiology       Date:  2003-09-13       Impact factor: 2.804

10.  Homeostatic mechanisms in dopamine synthesis and release: a mathematical model.

Authors:  Janet A Best; H Frederik Nijhout; Michael C Reed
Journal:  Theor Biol Med Model       Date:  2009-09-10       Impact factor: 2.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.